Skip to main content
. 2021 Jan 25;5(1):011501. doi: 10.1063/5.0029860

FIG. 1.

FIG. 1.

Schematic illustration of liposome-encapsulated therapies. (Left) FDA-approved therapies for chemotherapeutic-encapsulated liposomes (top left) without PEGylation and (bottom left) with PEGylation. (Right) Peptide-functionalized liposomes for receptor-targeted chemotherapeutic delivery.